Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study Josefina Cortés-Hernández, Carlos Marras Fernández-Cid, Jose Luis Andreu Sánchez, Jaime Calvo Alén, Angel M. García-Aparicio, Elvira Díez Álvarez, Francisco Javier Hidalgo Bermejo, Carlos Coronell, Alessandra Perna, Josep Ordi Ros

Osteonecrosis in individuals with systemic lupus erythematosus: A predictive model Jennifer Mendoza-Alonzo, José Zayas-Castro, Karina Soto-Sandoval

Severe and life-threatening onset of systemic lupus erythematosus Ana Martins, Sofia Pimenta, Daniela Oliveira, Frederico Martins, Beatriz Samões, Lúcia Costa